Fidia Revenue

In the year 2024, Fidia had annual revenue of 17.53M EUR, down -38.98%. Fidia had revenue of 8.11M in the half year ending December 31, 2024, a decrease of -46.72%.

Revenue

17.53M

Revenue Growth

-38.98%

P/S Ratio

0.22

Revenue / Employee

110.28K

Employees

159

Market Cap

3.88M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	17.53M	-11.20M	-38.98%
Dec 31, 2023	28.74M	4.07M	16.52%
Dec 31, 2022	24.66M	485.00K	2.01%
Dec 31, 2021	24.18M	2.52M	11.65%
Dec 31, 2020	21.65M	-24.55M	-53.13%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Leonardo S.p.a.	18.26B
Poste Italiane	13.64B
Prysmian	18.18B
Fincantieri	7.95B
Iveco Group	14.95B
Interpump Group	2.05B
Maire	6.32B
Webuild	11.03B

Revenue Rankings

Fidia News

6 hours ago - Pfizer bid to expand Talzenna label in prostate cancer rejected by FDA - Seeking Alpha
23 hours ago - KalVista said FDA will not meet review date for sebetralstat - Seeking Alpha
1 day ago - Why UroGen Pharma (URGN) Stock Is Skyrocketing This Week - Benzinga
1 day ago - FDA approves expanded use of Moderna's RSV shot, but uncertainty remains - The Hill
1 day ago - FDA approves expanded use of Modernas RSV shot, but uncertainty remains - Yahoo
1 day ago - Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery - Benzinga
1 day ago - FDA Approves UroGen's Zusduri As First Drug For Recurrent Bladder Cancer - Benzinga
1 day ago - Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda - Investopedia

More News